CN108552451B - Functional beverage after sports - Google Patents
Functional beverage after sports Download PDFInfo
- Publication number
- CN108552451B CN108552451B CN201810326524.8A CN201810326524A CN108552451B CN 108552451 B CN108552451 B CN 108552451B CN 201810326524 A CN201810326524 A CN 201810326524A CN 108552451 B CN108552451 B CN 108552451B
- Authority
- CN
- China
- Prior art keywords
- component
- provides
- vitamin
- function
- substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000020510 functional beverage Nutrition 0.000 title claims abstract description 30
- 239000000843 powder Substances 0.000 claims abstract description 84
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 47
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 47
- 235000021119 whey protein Nutrition 0.000 claims abstract description 47
- 229940024606 amino acid Drugs 0.000 claims abstract description 45
- 235000001014 amino acid Nutrition 0.000 claims abstract description 45
- 150000001413 amino acids Chemical class 0.000 claims abstract description 45
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 41
- 150000005693 branched-chain amino acids Chemical class 0.000 claims abstract description 40
- 235000018102 proteins Nutrition 0.000 claims abstract description 39
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 39
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims abstract description 37
- 241000209140 Triticum Species 0.000 claims abstract description 35
- 235000021307 Triticum Nutrition 0.000 claims abstract description 35
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 claims abstract description 32
- 235000019742 Vitamins premix Nutrition 0.000 claims abstract description 30
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 30
- 239000011707 mineral Substances 0.000 claims abstract description 30
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims abstract description 29
- 102000008186 Collagen Human genes 0.000 claims abstract description 27
- 108010035532 Collagen Proteins 0.000 claims abstract description 27
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 26
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 25
- 229920001436 collagen Polymers 0.000 claims abstract description 24
- 235000008939 whole milk Nutrition 0.000 claims abstract description 24
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims abstract description 23
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229960002429 proline Drugs 0.000 claims abstract description 23
- 108010073771 Soybean Proteins Proteins 0.000 claims abstract description 22
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims abstract description 21
- 229960000310 isoleucine Drugs 0.000 claims abstract description 21
- 229960003136 leucine Drugs 0.000 claims abstract description 21
- 239000000203 mixture Substances 0.000 claims abstract description 21
- 235000019710 soybean protein Nutrition 0.000 claims abstract description 21
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims abstract description 18
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229960002591 hydroxyproline Drugs 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 18
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229930182844 L-isoleucine Natural products 0.000 claims abstract description 16
- 239000004395 L-leucine Substances 0.000 claims abstract description 16
- 235000019454 L-leucine Nutrition 0.000 claims abstract description 16
- 229940026510 theanine Drugs 0.000 claims abstract description 15
- 239000004375 Dextrin Substances 0.000 claims abstract description 13
- 229920001353 Dextrin Polymers 0.000 claims abstract description 13
- 229930091371 Fructose Natural products 0.000 claims abstract description 13
- 239000005715 Fructose Substances 0.000 claims abstract description 13
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 13
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 13
- 235000019425 dextrin Nutrition 0.000 claims abstract description 13
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 13
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 13
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims abstract description 13
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims abstract description 13
- 229960003080 taurine Drugs 0.000 claims abstract description 13
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims abstract description 12
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims abstract description 12
- 229960002989 glutamic acid Drugs 0.000 claims abstract description 12
- 235000013922 glutamic acid Nutrition 0.000 claims abstract description 12
- 239000004220 glutamic acid Substances 0.000 claims abstract description 12
- 244000269722 Thea sinensis Species 0.000 claims abstract 9
- 239000004615 ingredient Substances 0.000 claims abstract 2
- 239000000126 substance Substances 0.000 claims description 48
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 21
- 235000010755 mineral Nutrition 0.000 claims description 19
- 229960004295 valine Drugs 0.000 claims description 18
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 14
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 14
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 14
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 14
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 14
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 14
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 14
- 239000011630 iodine Substances 0.000 claims description 14
- 229910052740 iodine Inorganic materials 0.000 claims description 14
- 239000011777 magnesium Substances 0.000 claims description 14
- 229910052749 magnesium Inorganic materials 0.000 claims description 14
- 239000011574 phosphorus Substances 0.000 claims description 14
- 229910052698 phosphorus Inorganic materials 0.000 claims description 14
- 239000011591 potassium Substances 0.000 claims description 14
- 229910052700 potassium Inorganic materials 0.000 claims description 14
- 229910052711 selenium Inorganic materials 0.000 claims description 14
- 239000011669 selenium Substances 0.000 claims description 14
- 239000011734 sodium Substances 0.000 claims description 14
- 229910052708 sodium Inorganic materials 0.000 claims description 14
- 239000011701 zinc Substances 0.000 claims description 14
- 229910052725 zinc Inorganic materials 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 10
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical group OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical group OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 7
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 7
- 239000011575 calcium Substances 0.000 claims description 7
- 229910052791 calcium Inorganic materials 0.000 claims description 7
- 229910052742 iron Inorganic materials 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical group CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 7
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical group OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 5
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 5
- 229960002477 riboflavin Drugs 0.000 claims description 5
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical group Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 4
- 229930003451 Vitamin B1 Natural products 0.000 claims description 4
- 229930003779 Vitamin B12 Natural products 0.000 claims description 4
- 229930003471 Vitamin B2 Natural products 0.000 claims description 4
- 229930003268 Vitamin C Natural products 0.000 claims description 4
- 229930003316 Vitamin D Natural products 0.000 claims description 4
- 229930003427 Vitamin E Natural products 0.000 claims description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical group OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 4
- 125000004057 biotinyl group Chemical group [H]N1C(=O)N([H])[C@]2([H])[C@@]([H])(SC([H])([H])[C@]12[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 claims description 4
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical group [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 4
- 125000003929 folic acid group Chemical group 0.000 claims description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 4
- 125000000627 niacin group Chemical group 0.000 claims description 4
- 125000003201 pantothenic acid group Chemical group 0.000 claims description 4
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 4
- 229960003495 thiamine Drugs 0.000 claims description 4
- 235000019155 vitamin A Nutrition 0.000 claims description 4
- 239000011719 vitamin A Substances 0.000 claims description 4
- 235000010374 vitamin B1 Nutrition 0.000 claims description 4
- 239000011691 vitamin B1 Substances 0.000 claims description 4
- 235000019163 vitamin B12 Nutrition 0.000 claims description 4
- 239000011715 vitamin B12 Substances 0.000 claims description 4
- 235000019164 vitamin B2 Nutrition 0.000 claims description 4
- 239000011716 vitamin B2 Substances 0.000 claims description 4
- 235000019158 vitamin B6 Nutrition 0.000 claims description 4
- 239000011726 vitamin B6 Substances 0.000 claims description 4
- 235000019154 vitamin C Nutrition 0.000 claims description 4
- 239000011718 vitamin C Substances 0.000 claims description 4
- 235000019166 vitamin D Nutrition 0.000 claims description 4
- 239000011710 vitamin D Substances 0.000 claims description 4
- 150000003710 vitamin D derivatives Chemical group 0.000 claims description 4
- 235000019165 vitamin E Nutrition 0.000 claims description 4
- 239000011709 vitamin E Substances 0.000 claims description 4
- 229940046009 vitamin E Drugs 0.000 claims description 4
- 229940045997 vitamin a Drugs 0.000 claims description 4
- 229940011671 vitamin b6 Drugs 0.000 claims description 4
- 229940046008 vitamin d Drugs 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 3
- 239000007858 starting material Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 235000016709 nutrition Nutrition 0.000 abstract description 5
- 230000035764 nutrition Effects 0.000 abstract description 3
- 241001122767 Theaceae Species 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 14
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 14
- 239000003094 microcapsule Substances 0.000 description 13
- 230000006870 function Effects 0.000 description 12
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 10
- 239000000945 filler Substances 0.000 description 10
- 210000003205 muscle Anatomy 0.000 description 10
- 239000004474 valine Substances 0.000 description 10
- 102000004420 Creatine Kinase Human genes 0.000 description 9
- 108010042126 Creatine kinase Proteins 0.000 description 9
- 235000015097 nutrients Nutrition 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 229960000890 hydrocortisone Drugs 0.000 description 7
- 229960003604 testosterone Drugs 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 6
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 5
- 239000005913 Maltodextrin Substances 0.000 description 5
- 229920002774 Maltodextrin Polymers 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 5
- 229940088597 hormone Drugs 0.000 description 5
- 239000005556 hormone Substances 0.000 description 5
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 5
- 229940035034 maltodextrin Drugs 0.000 description 5
- 229960003975 potassium Drugs 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 229940091258 selenium supplement Drugs 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- -1 branched chain amino acid BCAAs Chemical class 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 2
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 2
- ZESRJSPZRDMNHY-YFWFAHHUSA-N 11-deoxycorticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 ZESRJSPZRDMNHY-YFWFAHHUSA-N 0.000 description 2
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 2
- DBPWSSGDRRHUNT-UHFFFAOYSA-N 17alpha-hydroxy progesterone Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C(=O)C)(O)C1(C)CC2 DBPWSSGDRRHUNT-UHFFFAOYSA-N 0.000 description 2
- DBPWSSGDRRHUNT-CEGNMAFCSA-N 17α-hydroxyprogesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2 DBPWSSGDRRHUNT-CEGNMAFCSA-N 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 description 2
- PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
- 208000025978 Athletic injury Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- OMFXVFTZEKFJBZ-UHFFFAOYSA-N Corticosterone Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 OMFXVFTZEKFJBZ-UHFFFAOYSA-N 0.000 description 2
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 2
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 2
- FMGSKLZLMKYGDP-UHFFFAOYSA-N Dehydroepiandrosterone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CC=C21 FMGSKLZLMKYGDP-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- BZQFBWGGLXLEPQ-UHFFFAOYSA-N O-phosphoryl-L-serine Natural products OC(=O)C(N)COP(O)(O)=O BZQFBWGGLXLEPQ-UHFFFAOYSA-N 0.000 description 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- CZWCKYRVOZZJNM-UHFFFAOYSA-N Prasterone sodium sulfate Natural products C1C(OS(O)(=O)=O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CC=C21 CZWCKYRVOZZJNM-UHFFFAOYSA-N 0.000 description 2
- 108010077895 Sarcosine Proteins 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 206010041738 Sports injury Diseases 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 229960003767 alanine Drugs 0.000 description 2
- 229960002478 aldosterone Drugs 0.000 description 2
- QWCKQJZIFLGMSD-UHFFFAOYSA-N alpha-aminobutyric acid Chemical compound CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 description 2
- AEMFNILZOJDQLW-QAGGRKNESA-N androst-4-ene-3,17-dione Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 AEMFNILZOJDQLW-QAGGRKNESA-N 0.000 description 2
- 229960003473 androstanolone Drugs 0.000 description 2
- AEMFNILZOJDQLW-UHFFFAOYSA-N androstenedione Natural products O=C1CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 AEMFNILZOJDQLW-UHFFFAOYSA-N 0.000 description 2
- 229960005471 androstenedione Drugs 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 235000009582 asparagine Nutrition 0.000 description 2
- 229960002173 citrulline Drugs 0.000 description 2
- 235000013477 citrulline Nutrition 0.000 description 2
- OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 description 2
- 229960004544 cortisone Drugs 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 229960002433 cysteine Drugs 0.000 description 2
- ZESRJSPZRDMNHY-UHFFFAOYSA-N de-oxy corticosterone Natural products O=C1CCC2(C)C3CCC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 ZESRJSPZRDMNHY-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 description 2
- CZWCKYRVOZZJNM-USOAJAOKSA-N dehydroepiandrosterone sulfate Chemical compound C1[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 CZWCKYRVOZZJNM-USOAJAOKSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 229950006137 dexfosfoserine Drugs 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 238000004146 energy storage Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229960005309 estradiol Drugs 0.000 description 2
- 229930182833 estradiol Natural products 0.000 description 2
- 229960003399 estrone Drugs 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 229960003104 ornithine Drugs 0.000 description 2
- BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 2
- 229960002847 prasterone Drugs 0.000 description 2
- 229950009829 prasterone sulfate Drugs 0.000 description 2
- 239000000186 progesterone Substances 0.000 description 2
- 229960003387 progesterone Drugs 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical group Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 229940043230 sarcosine Drugs 0.000 description 2
- 229940071440 soy protein isolate Drugs 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 229960002898 threonine Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- ASYBZHICIMVQII-AKGZTFGVSA-N 4-hydroxy-L-lysine Chemical compound NCCC(O)C[C@H](N)C(O)=O ASYBZHICIMVQII-AKGZTFGVSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 239000011665 D-biotin Substances 0.000 description 1
- 235000000638 D-biotin Nutrition 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- DATAGRPVKZEWHA-UHFFFAOYSA-N L-gamma-glutamyl-n-ethylamine Natural products CCNC(=O)CCC(N)C(O)=O DATAGRPVKZEWHA-UHFFFAOYSA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- 102000008934 Muscle Proteins Human genes 0.000 description 1
- 108010074084 Muscle Proteins Proteins 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 229930003761 Vitamin B9 Natural products 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical group 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000011706 ferric diphosphate Substances 0.000 description 1
- 235000007144 ferric diphosphate Nutrition 0.000 description 1
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 description 1
- 229940036404 ferric pyrophosphate Drugs 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000012395 formulation development Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 230000009955 peripheral mechanism Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- JLKDVMWYMMLWTI-UHFFFAOYSA-M potassium iodate Chemical compound [K+].[O-]I(=O)=O JLKDVMWYMMLWTI-UHFFFAOYSA-M 0.000 description 1
- 239000001230 potassium iodate Substances 0.000 description 1
- 235000006666 potassium iodate Nutrition 0.000 description 1
- 229940093930 potassium iodate Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 235000019187 sodium-L-ascorbate Nutrition 0.000 description 1
- 239000011755 sodium-L-ascorbate Substances 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 235000014268 sports nutrition Nutrition 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000019159 vitamin B9 Nutrition 0.000 description 1
- 239000011727 vitamin B9 Substances 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a functional beverage after sports. The composition of amino acids provided in the present invention comprises 7 effective ingredients: hydroxyproline, proline, glutamic acid, theanine, L-leucine, L-isoleucine and L-valine; the mass ratio is as follows in sequence: 0.2-1: 0.2-1: 2-5: 0.05-0.3: 1-3: 0.5-1.5: 0.5-1.5. The product of the invention comprises the following raw materials: wheat protein, whole milk powder, hydrolyzed whey protein peptide, whey protein powder, soybean protein isolate powder, collagen, branched chain amino acid, tea amino acid, crystalline fructose, fructo-oligosaccharide, sodium carboxymethylcellulose, resistant dextrin, taurine, vitamin premix and mineral premix. The composition or the product can be used for: preparing a functional beverage to be taken after exercise; can be used as functional beverage for patients after exercise. The invention fills the blank of accurate nutrition supply of the ultimate endurance events in China.
Description
Technical Field
The invention relates to a functional beverage after sports.
Background
At present, various protein powder, branched chain amino acid BCAAs, L-glutamine, theanine and collagen supplement nutriments are available on the market, but most of the nutriments are limited to one or the combination of one or two of the protein powder, and the synergic research of various functional amino acids based on Chinese population data is almost blank.
The prior art has slow effect because of single functional component. Especially, basic data research of large sample multiomics and comprehensive research data of Chinese people are lacked, so that recovery products are often not considered comprehensively after corresponding endurance sports are designed, and no sports recovery products particularly aiming at specific national constitutions or accurate nutrition supplement products aiming at high-strength endurance sports events are available.
Hydroxyproline and proline are nutrients which are easy to lose after strenuous exercise, and the existing sports nutrition products in the market are less added, and are particularly applied to extreme endurance events.
Disclosure of Invention
The invention aims to provide a functional beverage after sports.
The invention firstly provides a composition for providing amino acid, which comprises the following 7 effective components: hydroxyproline, proline, glutamic acid, theanine, L-leucine, L-isoleucine and L-valine;
the mass ratio of hydroxyproline, proline, glutamic acid, theanine, L-leucine, L-isoleucine and L-valine is as follows in sequence: 0.2-1: 0.2-1: 2-5: 0.05-0.3: 1-3: 0.5-1.5: 0.5-1.5.
The mass ratio of hydroxyproline, proline, glutamic acid, theanine, L-leucine, L-isoleucine and L-valine is as follows in sequence: 0.7: 0.9 g: 3.6 g: 0.07: 2.13: 1.12: 1.12.
the raw materials of the composition comprise: wheat protein (specifically concentrated wheat protein), whole milk powder, hydrolyzed whey protein peptide, whey protein powder, soybean protein isolate powder, collagen protein, branched chain amino acid (specifically branched chain amino acid microcapsule powder), and tea amino acid.
The composition comprises the following raw materials: wheat protein (specifically concentrated wheat protein), whole milk powder, hydrolyzed whey protein peptide, whey protein powder, soybean protein isolate powder, collagen protein, branched chain amino acid (specifically branched chain amino acid microcapsule powder), and tea amino acid.
The weight ratio of wheat protein (specifically concentrated wheat protein), whole milk powder, hydrolyzed whey protein peptide, whey protein powder, soybean protein isolate powder, collagen, branched chain amino acid (specifically branched chain amino acid microcapsule powder) and tea amino acid is as follows: 6.37: 4.5: 2.15: 1.5: 1.5: 1.43: 2.8: 0.28.
the invention also provides a product comprising the composition as described in any one of the above.
The raw materials of the product comprise: wheat protein (specifically concentrated wheat protein), whole milk powder, hydrolyzed whey protein peptide, whey protein powder, soybean protein isolate powder, collagen protein, branched chain amino acid ()
The raw materials of the product comprise: wheat protein (specifically concentrated wheat protein), whole milk powder, hydrolyzed whey protein peptide, whey protein powder, soybean protein isolate powder, collagen, branched chain amino acid (specifically branched chain amino acid microcapsule powder), tea amino acid, vitamin premix and mineral premix.
The mass ratio of wheat protein (specifically concentrated wheat protein), whole milk powder, hydrolyzed whey protein peptide, whey protein powder, soybean protein isolate powder, collagen, branched chain amino acid (specifically branched chain amino acid microcapsule powder), tea amino acid, vitamin premix and mineral premix is 6.37: 4.5: 2.15: 1.5: 1.5: 1.43: 2.8: 0.28: 0.13: 0.81.
the raw materials of the product comprise: wheat protein (specifically concentrated wheat protein), whole milk powder, hydrolyzed whey protein peptide, whey protein powder, soybean protein isolate powder, collagen, branched chain amino acid (specifically branched chain amino acid microcapsule powder), tea amino acid, crystalline fructose, fructo-oligosaccharide, sodium carboxymethylcellulose, resistant dextrin, taurine, vitamin premix and mineral premix.
The raw materials of the product comprise: wheat protein (specifically concentrated wheat protein), whole milk powder, hydrolyzed whey protein peptide, whey protein powder, soybean protein isolate powder, collagen, branched chain amino acid (specifically branched chain amino acid microcapsule powder), tea amino acid, crystalline fructose, fructo-oligosaccharide, sodium carboxymethylcellulose, resistant dextrin, taurine, vitamin premix and mineral premix.
The mass ratio of wheat protein (specifically concentrated wheat protein), whole milk powder, hydrolyzed whey protein peptide, whey protein powder, soybean protein isolate powder, collagen, branched chain amino acid (specifically branched chain amino acid microcapsule powder), tea amino acid, crystalline fructose, fructo-oligosaccharide, sodium carboxymethyl cellulose, resistant dextrin, taurine, vitamin premix and mineral premix is 6.37: 4.5: 2.15: 1.5: 1.5: 1.43: 2.8: 0.28: 5.07: 0.9: 0.8: 1.72: 0.04: 0.13: 0.81.
the invention also provides a preparation method of the product, which comprises the following steps:
(1) mixing vitamin premix, mineral premix, tea amino acid and taurine to obtain a mixed material A;
(2) mixing the mixture A, soybean protein isolate powder, branched chain amino acid (specifically branched chain amino acid microcapsule powder), resistant dextrin, sodium carboxymethylcellulose, fructo-oligosaccharide, collagen, whey protein powder, hydrolyzed whey protein peptide, whole milk powder, crystalline fructose, and wheat protein (specifically concentrated wheat protein), and mixing to obtain the final product.
In the preparation method of the product, the mass ratio of the wheat protein (specifically concentrated wheat protein), the whole milk powder, the hydrolyzed whey protein peptide, the whey protein powder, the isolated soy protein powder, the collagen, the branched chain amino acid (specifically branched chain amino acid microcapsule powder), the tea amino acid, the crystalline fructose, the fructo-oligosaccharide, the sodium carboxymethylcellulose, the resistant dextrin, the taurine, the vitamin premix and the mineral premix is 6.37: 4.5: 2.15: 1.5: 1.5: 1.43: 2.8: 0.28: 5.07: 0.9: 0.8: 1.72: 0.04: 0.13: 0.81.
the product prepared by the method also belongs to the protection scope of the invention.
The function of any of the above products is (a1), (a2) or (a 3):
(a1) providing an amino acid;
(a2) preparing a functional beverage to be taken after exercise;
(a3) can be used as functional beverage for patients after exercise.
The composition or the product provided by the invention can be used in the fields of food and health care products.
The compositions or products provided by the present invention may be used in a variety of dosage forms. Such as solid beverages, liquid beverages, energy gels, energy bars (nutritional bars), capsules, tablets, and the like.
The invention also protects the application of any one of the compositions or the products, which is (b1) or (b 2):
(b1) preparing a functional beverage to be taken after exercise;
(b2) can be used as functional beverage for patients after exercise.
The functional beverage is solid beverage or liquid beverage. When the functional beverage is a solid beverage, the functional beverage can be drunk after being mixed with water.
Any one of the vitamin premixes comprises the following 12 effective components: the component I-1, the component I-2, the component I-3, the component I-4, the component I-5, the component I-6, the component I-7, the component I-8, the component I-9, the component I-10, the component I-11 and the component I-12;
component I-1 provides a substance having a vitamin A function, component I-2 provides a substance having a vitamin B1 function, component I-3 provides a substance having a vitamin B2 function, component I-4 provides a substance having a vitamin B3 function, component I-5 provides a substance having a vitamin B5 function, component I-6 provides a substance having a vitamin B6 function, component I-7 provides a substance having a vitamin B9 function, component I-8 provides a substance having a vitamin B12 function, component I-9 provides a substance having a vitamin C function, component I-10 provides a substance having a vitamin D function, component I-11 provides a substance having a vitamin E function, and component I-12 provides a substance having a vitamin H function;
the proportion of the component I-1, the component I-2, the component I-3, the component I-4, the component I-5, the component I-6, the component I-7, the component I-8, the component I-9, the component I-10, the component I-11 and the component I-12 is 1100-: 14.22-21.33 mg: 7.112-10.67 mg: 49.11-73.67 mg: 17.33-26.00 mg: 7.112-10.67 mg: 888.9-1333 μ g: 14.22-21.33. mu.g: 255.5-383.3 mg: 25.55-38.33. mu.g: 49.12-73.68 mg: 121.12-181.68 μ g.
Any one of the mineral premix comprises the following 9 effective components: component II-1, component II-2, component II-3, component II-4, component II-5, component II-6, component II-7, component II-8 and component II-9;
the component II-1 provides a sodium element, the component II-2 provides a phosphorus element, the component II-3 provides a potassium element, the component II-4 provides a magnesium element, the component II-5 provides a calcium element, the component II-6 provides an iron element, the component II-7 provides a zinc element, the component II-8 provides a selenium element, and the component II-9 provides an iodine element;
the ratio of sodium element provided by the component II-1, phosphorus element provided by the component II-2, potassium element provided by the component II-3, magnesium element provided by the component II-4, calcium element provided by the component II-5, iron element provided by the component II-6, zinc element provided by the component II-7, selenium element provided by the component II-8 and iodine element provided by the component II-9 is 85.19-127.8mg in sequence: 40.92-61.39 mg: 85.18-127.8 mg: 13.08-19.61 mg: 35.19-52.78 mg: 1.2088-1.8134 mg: 1.4226-2.134 mg: 2.208-3.312 μ g: 3.614-5.420 μ g.
The mixture ratio of the component I-1, the component I-2, the component I-3, the component I-4, the component I-5, the component I-6, the component I-7, the component I-8, the component I-9, the component I-10, the component I-11 and the component I-12 is 1375 mu g: 17.78 mg: 8.89 mg: 61.39 mg: 21.67 mg: 8.89 mg: 1111 μ g: 17.78 μ g: 319.4 mg: 31.94 μ g: 61.4 mg: 151.4 μ g.
The ratio of sodium element provided by the component II-1, phosphorus element provided by the component II-2, potassium element provided by the component II-3, magnesium element provided by the component II-4, calcium element provided by the component II-5, iron element provided by the component II-6, zinc element provided by the component II-7, selenium element provided by the component II-8 and iodine element provided by the component II-9 is 106.5 mg: 51.16 mg: 106.49 mg: 16.35 mg: 43.99 mg: 1.52 mg: 1.78 mg: 2.76 μ g: 4.52. mu.g.
The vitamin premix consists of a component I-1, a component I-2, a component I-3, a component I-4, a component I-5, a component I-6, a component I-7, a component I-8, a component I-9, a component I-10, a component I-11, a component I-12 and a filler.
Each 1g of the vitamin premix comprises a component I-1, a component I-2, a component I-3, a component I-4, a component I-5, a component I-6, a component I-7, a component I-8, a component I-9, a component I-10, a component I-11 and a component I-12 which are 1100-1650 mu g, 14.22-21.33mg, 7.112-10.67mg, 49.11-73.67mg, 17.33-26.00mg, 7.112-10.67mg, 888.9-1333 mu g, 14.22-21.33 mu g, 255.5-383.3mg, 25.55-38.33 mu g, 49.12-73.68mg and 121.12-181.68 mu g in sequence.
The mineral premix consists of a component II-1, a component II-2, a component II-3, a component II-4, a component II-5, a component II-6, a component II-7, a component II-8, a component II-9 and a filler.
Each 1g of the mineral premix contains sodium provided by the component II-1, phosphorus provided by the component II-2, potassium provided by the component II-3, magnesium provided by the component II-4, calcium provided by the component II-5, iron provided by the component II-6, zinc provided by the component II-7, selenium provided by the component II-8 and iodine provided by the component II-9 in the order of 85.19-127.8mg, 40.92-61.39mg, 85.18-127.8mg, 13.08-19.61mg, 35.19-52.78mg, 1.2088-1.8134mg, 1.4226-2.134mg, 2.208-3.312 μ g and 3.614-5.420 μ g.
Each 1g of the vitamin premix comprises 1375 mug of component I-1, 17.78mg, 8.89mg, 61.39mg, 21.67mg, 8.89mg, 1111 mug of, 17.78 mug of, 319.4mg, 31.94 mug of, 61.4mg and 151.4 mug of component I-3, component I-4, component I-5, component I-6, component I-7, component I-8, component I-9, component I-10, component I-11 and component I-12 in sequence.
The contents of sodium element provided by the component II-1, phosphorus element provided by the component II-2, potassium element provided by the component II-3, magnesium element provided by the component II-4, calcium element provided by the component II-5, iron element provided by the component II-6, zinc element provided by the component II-7, selenium element provided by the component II-8 and iodine element provided by the component II-9 in each 1g of the mineral premix were 106.5mg, 51.16mg, 106.49mg, 16.35mg, 43.99mg, 1.52mg, 1.78mg, 2.76 μ g and 4.52 μ g, respectively.
The vitamin A acetate is used as the component I-1, the thiamine hydrochloride is used as the component I-2, the riboflavin is used as the component I-3, the nicotinamide is used as the component I-4, the calcium D-pantothenate is used as the component I-5, the pyridoxine hydrochloride is used as the component I-6, the vitamin B9 is used as the component I-7, the cyanocobalamine is used as the component I-8, the sodium L-ascorbate is used as the component I-9, the vitamin D3 is used as the component I-10, the dl-alpha-tocopherol acetate is used as the component I-11, and the D-biotin is used as the component I-12.
The component II-1 is sodium citrate and/or disodium hydrogen phosphate, the component II-2 is disodium hydrogen phosphate, the component II-3 is potassium citrate and/or potassium chloride, the component II-4 is magnesium carbonate, the component II-5 is calcium carbonate, the component II-6 is ferric pyrophosphate, the component II-7 is zinc sulfate, the component II-8 is sodium selenite, and the component II-9 is potassium iodate.
The composition provided by the invention is based on comprehensive human multigroup data before and after endurance exercise, functional nutrients and easily-lost nutrients are determined by monitoring the change condition of the nutrients, and accurate supplement of amino acid components such as branched-chain amino acid BCAAs (valine, leucine, isoleucine), glutamine, theanine, hydroxyproline, proline and the like is realized by combining several food raw materials such as concentrated wheat protein, whole milk powder, hydrolyzed whey protein peptide, whey protein powder, soybean protein isolate powder, collagen, branched-chain amino acid microcapsule powder and tea amino acid, so that the body recovery after endurance exercise is rapidly promoted.
The functional beverage can achieve the following effects: inhibiting creatine kinase fluctuation, increasing levels of valine, L-leucine, L-isoleucine and proline, and supplementing functional beverage after exercise for a certain time to relieve exercise injury and accelerate repair of injury after exercise. The composition provided by the invention is mainly characterized in that nutrients are integrally and comprehensively supplemented based on multiple groups of mathematical data, so that the effect is better than that of a single or individual combination of nutrients.
The invention fills the blank of accurate nutrition supply of the ultimate endurance events in China.
Drawings
FIG. 1 shows the average fluctuation ratio of amino acids.
FIG. 2 is the mean hormone fluctuation rate.
Fig. 3 is a graph of creatine kinase changes at different time points.
Figure 4 is a graph of the change in creatine kinase levels at different time points in a subject.
FIG. 5 is a graph of valine level changes at different time points in subjects.
FIG. 6 is a graph of the change in L-isoleucine levels at different time points in a subject.
FIG. 7 is a graph of changes in L-leucine levels at different time points in a subject.
Figure 8 is a graph of changes in proline levels at different time points in subjects.
Detailed Description
The following examples are given to facilitate a better understanding of the invention, but do not limit the invention. The experimental procedures in the following examples are conventional unless otherwise specified. The test materials used in the following examples were purchased from a conventional biochemical reagent store unless otherwise specified. The quantitative tests in the following examples, all set up three replicates and the results averaged. The content of each amino acid is detected by adopting a method for measuring the amino acid in the food in GB/T5009.124-2003. Theanine (L-Theanine) is a free amino acid unique to tea leaves and is glutamic acid γ -ethylamide. Detecting the content of theanine in the amino acid of the tea by adopting a method for measuring the total amount of free amino acid in the tea in GB/T8314-2013. Maltodextrin, 2: west king sugar industry Co.
The concentrated wheat protein in the examples is SYRAL wheat protein, Shanghai jicheng,500,http://www.jebsenindustrial.com/%E5%85%B3%E4%BA%8E%E6%88%91%E4%BB%AC/%E5%90%88%E4%BD%9C%E4%BC%99%E4%BC%B4/syral/syral%E5%B0%8F%E9%BA%A6%E8%9B%8B%E7%99%BD/。
the whole milk powder used in the examples was a natural whole milk powder, cat # 113120.
The whey protein powder used in the examples was HILMAR8010 concentrated whey protein powder.
The soy protein isolate used in the examples was DuPont SUPRO 787 soy protein isolate.
The collagen used in the examples was fish collagen peptide: shanghai Tongyuan health care science and technology, goods number GBB-50SP 757.
Branched chain amino acid microcapsule powders used in examples: dalian Deno Bio Inc., cat # 60102-P.
The tea amino acids used in the examples were natural tea amino acids (the Shanghai Node organism is a natural tea amino acid from Engineer, Inc., Tennova TM L20) and the website is http:// www.novanat.com/showproduct. aspag ═ c & id ═ 80.
Example 1 formulation development of functional drink after exercise
First, formula development process
The eight hundred quicksand limit event is the first super-long-distance uninterrupted, self-navigation and self-loading cross-country running event in China; and (4) limit examination: high-load motion state, ultra-long distance and severe environment; limited supply and lack of rest, and the physiological function of athletes can be tested. The Huada sports is used as a Huada gene flag setting mechanism, and provides the athlete with omnibearing detection services before, during, after and two weeks after the match. The assessment is carried out from the aspects of gene, metabolism, sports physiology, psychology, overall sports health of athletes and the like, and personalized suggestions are provided, so that a basis is provided for making a more scientific sports plan.
Amino acid fluctuation rate (post-race level-pre-race level)/pre-race level × 100%. The average fluctuation rate of amino acids is shown in FIG. 1, with negative values indicating decreased levels and positive values indicating increased levels. In fig. 1, hydroxyproline, proline, ornithine, valine, alanine, sarcosine, cysteine, isoleucine, leucine, phosphoserine, citrulline, glycine, threonine, γ -hydroxylysine, lysine, serine, tryptophan, α -amino-n-butyric acid, and asparagine are sequentially arranged from left to right. The average fluctuation rate of hydroxyproline is-54%, the average fluctuation rate of proline is-47%, the average fluctuation rate of ornithine is-44%, the average fluctuation rate of valine is-39%, the average fluctuation rate of alanine is-38%, the average fluctuation rate of sarcosine is-32%, the average fluctuation rate of cysteine is-30%, the average fluctuation rate of isoleucine is-24%, the average fluctuation rate of leucine is-24%, the average fluctuation rate of phosphoserine is-22%, the average fluctuation rate of citrulline is-22%, the average fluctuation rate of glycine is-22%, the average fluctuation rate of threonine is-20%, the average fluctuation rate of gamma-hydroxylysine is-17%, the average fluctuation rate of lysine is-11%, the average fluctuation rate of serine is-9.3%, The mean fluctuation ratio of tryptophan was-7.5%, the mean fluctuation ratio of α -aminon-butyric acid was-6.4%, and the mean fluctuation ratio of asparagine was-4.7%. Athletes lose more of 3 Branched Chain Amino Acids (BCAAs) (valine, isoleucine, leucine): the loss ratio of the three amino acids is 24-40%. The loss of the branched chain amino acid BCAAs accelerates the muscle decomposition process, generates stronger sports fatigue feeling and reduces the sports ability. The two amino acids with the greatest player churn rate are hydroxyproline and proline. Collagen contains hydroxyproline and proline in high proportion, and the specific amino acids are nutrients which are easy to lose after strenuous exercise. Collagen plays an important role in the development, differentiation and formation of individuals as well as other connective tissues, and is closely related to the aging and diseases of the body.
Hormone fluctuation rate ═ (post-race level-pre-race level)/pre-race level × 100%. The mean hormone fluctuation is shown in FIG. 2, with negative values being lower and positive values being higher. In fig. 2, testosterone/cortisol, testosterone, 17-hydroxyprogesterone, progesterone, androstenedione, dehydroepiandrosterone, 11-deoxycorticosterone, cortisone, 11-deoxycorticosterol, estradiol, aldosterone, dihydrotestosterone, dehydroepiandrosterone sulfate, cortisol, estrone, and corticosterone are arranged in this order from left to right. The mean fluctuation rate of testosterone/cortisol was-75%, the mean fluctuation rate of testosterone was-63%, the mean fluctuation rate of 17-hydroxyprogesterone was-47%, the mean fluctuation rate of progesterone was-40%, the mean fluctuation rate of androstenedione was-38%, the mean fluctuation rate of dehydroepiandrosterone was-12%, the mean fluctuation rate of 11-deoxycorticosterone was 3.33%, the mean fluctuation rate of cortisone was 3.86%, the mean fluctuation rate of 11-deoxycorticosterol was 16.4%, the mean fluctuation rate of estradiol was 58.7%, the mean fluctuation rate of aldosterone was 69.6%, the mean fluctuation rate of dihydrotestosterone was 91.6%, the mean fluctuation rate of dehydroepiandrosterone sulfate was 107%, the mean fluctuation rate of cortisol was 126%, the mean fluctuation rate of estrone was 165%, and the mean fluctuation rate of corticosterone was 230%. Testosterone: muscle loss is accelerated. Cortisol: increase in body fatigue, and accelerate the decomposition of saccharides, fats and proteins. Testosterone/cortisol ratio: the reduction amplitude is more than 30%, and the athlete is excessive in movement on the whole.
Creatine kinase, lactate dehydrogenase, aspartate aminotransferase and alanine aminotransferase four muscle metabolic enzymes can be used to assess the degree of muscle damage. The graph of creatine kinase changes at different time points is shown in fig. 3. In fig. 3, time1 is before the start of the race, time 2 is 2 days after the start of the race (sixth replenishing point), time3 is after the end of the race, and time4 is 2 weeks after the end of the race. The four muscle enzymes have similar variation trends: normal before the race; the RP6 point (the sixth supply point) in the game rises to the highest value; decline after the race, do not return to the normal level; the decline continued two weeks after the race, but still did not return to the pre-race normal level. The eight hundred quicksand limit race has certain damage to the muscles of athletes, and the muscles of the athletes still do not recover to the normal level before the race even two weeks after the race.
Through continuous monitoring of athletes at different stages before, during and after the competition, the athlete finds that the loss rate of the amino acid level is high, especially branched chain amino acid, proline and hydroxyproline. At the same time, the hormone level (testosterone/cortisol ratio) is reduced by more than 30%, reflecting that long-term endurance exercise has obvious negative effects on the athlete's body, and the recovery is slow. Therefore, the corresponding nutritional support before, during and after the match is a very important link, and the body comfort of athletes can be improved by pertinently supplementing corresponding amino acids and adjusting related hormone levels, so that the repair of various functions of the body is accelerated.
Second, the core design of the formula
The core design of the formulation is shown in table 1.
TABLE 1
Component name | Mass ratio of | Design amount per day |
Hydroxyproline | 0.2-1 | 0.2-1g |
Proline | 0.2-1 | 0.2-1g |
Glutamic acid | 2-5 | 2-5g |
Theanine | 0.05-0.3 | 0.05-0.3g |
L-leucine | 1-3 | 1-3g |
L-isoleucine | 0.5-1.5 | 0.5-1.5g |
L-valine | 0.5-1.5 | 0.5-1.5g |
Example 2 preparation of premix
Vitamin premix
The vitamin premix consists of functional raw materials and a filler. The filler is maltodextrin. The content of each functional material in each 1g of the vitamin premix is shown in table 2.
TABLE 2
The vitamin premix used in example 3 was composed of functional raw materials and a filler. The filler is maltodextrin. The content of each functional material in the vitamin premix per unit mass is shown in table 3.
TABLE 3
Second, mineral premix
The mineral premix consists of functional raw materials and a filler. The filler is maltodextrin. The composition of each functional raw material per 1g of the mineral premix and the amount of the corresponding functional element provided by each functional raw material are shown in table 4.
TABLE 4
The mineral premix used in example 3 was composed of functional raw materials and fillers. The filler is maltodextrin. The contents of the respective functional materials in the mineral premix per unit mass are shown in table 5.
TABLE 5
Example 3 preparation of functional drink after exercise (solid drink)
1 person in 1 day after 1 bag of sports functional beverage, and 30g after 1 bag of sports functional beverage. The composition of the raw materials of the functional drink after exercise, the dosage (g) of the raw materials in each 30g of the functional drink after exercise, and the amount (g) of the nutrient elements provided by the raw materials in each 30g of the functional drink after exercise are shown in Table 6.
TABLE 6
Crystalline fructose: bowling Bao Bio Inc., cat # QR 0256. Fructo-oligosaccharide: SENSUS, cat No. 513E 801602. Sodium carboxymethylcellulose: the product number is FH 6. Resistant dextrin: batoka (shanghai) commercial ltd, cat # 338111W. Taurine: hubei Dashenghuashengshi science and technology, Inc., Cat No. C002-M1710621.
Crystalline fructose serves as an energy supplement and sweetener.
The fructo-oligosaccharide can be used as sweetener and intestinal buffer.
Sodium carboxymethyl cellulose is used as an adhesive.
The resistant dextrin acts as a bulking agent.
Taurine is used as a basic nutrient supplement.
The preparation process comprises the following steps:
1. fully mixing the vitamin premix, the mineral premix, the tea amino acid and the taurine to obtain a mixed material A.
2. The preparation method comprises the following steps of fully mixing a mixed material A, soybean protein isolate powder, branched chain amino acid microcapsule powder, resistant dextrin, sodium carboxymethylcellulose, fructo-oligosaccharide, collagen, whey protein powder, hydrolyzed whey protein peptide, whole milk powder, crystalline fructose and concentrated wheat protein to obtain a mixed material B.
3. And subpackaging the mixed material B, and 30g of the mixed material B is packaged in each bag.
According to detection, every 30g of functional beverage after exercise contains 3.6g of glutamic acid, 0.9g of proline, 0.7g of hydroxyproline, 2.13g of L-leucine, 1.12g of L-isoleucine, 1.12g of L-valine and 0.07g of theanine.
Example 4 Effect verification of functional beverages after exercise
The 60 runners (all volunteers with informed consent) were randomly divided into two groups of 30 each, using a randomized, parallel-control clinical trial.
Experimental groups (each as follows):
venous blood was collected 8 o' clock (time1) late on day 0 of the experiment;
day 1 to day 4 of the experiment: running for 20 km long in the morning (the running speed is controlled at 10 km/h), and taking a bag of functional beverage after exercise (taken after being mixed with boiled water) prepared in example 31 hour after running;
venous blood was collected on day 1 at 8 o 'clock (time1), day 4 at 8 o' clock (time3), day 7 at 8 o 'clock (time4), and day 14 at 8 o' clock (time5), respectively.
The control group did not take the functional drink after exercise prepared in example 3, and the other groups were the same as the experimental group.
The main functions of branched-chain amino acids (valine, leucine, isoleucine): improving exercise ability and delaying fatigue. Branched chain amino acids are a general term for 3 of 8 kinds of amino acids essential to the body, are essential nutrients for muscles, and account for 30% -40% of amino acids constituting muscles. Function of branched chain amino acids: the energy storage device is closely related to the exercise capacity of the human body and can provide energy storage for long-time endurance exercise; promoting muscle protein synthesis; anti-decomposition effects, which help to prevent protein decomposition and muscle loss, and to protect muscles; regulating a peripheral mechanism for inducing the exercise-induced fatigue and postponing the appearance of the exercise-induced fatigue; supplementation with branched-chain amino acids after exercise may also promote recovery from exercise-induced fatigue.
The levels of Creatine Kinase (CK), valine, L-leucine, L-isoleucine and proline in the plasma of venous blood collected at 5 time points were measured to evaluate the extent of exercise injury.
The graph of the creatine kinase level at different time points of the subject is shown in FIG. 4 (ordinate units are U/L). The profile of the valine levels at different time points is shown in FIG. 5 (ordinate units μmol/L). The L-isoleucine levels at different time points for the subjects are plotted in FIG. 6 (ordinate units μmol/L). The L-leucine level profile for the subjects at different time points is shown in FIG. 7 (ordinate units μmol/L). The profile of the change in proline levels at different time points in the subject is shown in FIG. 8 (ordinate units μmol/L). Compared with the experimental group, the creatine kinase level of the control group has larger fluctuation, and the levels of valine, L-leucine, L-isoleucine and proline are lower. The results show that the functional beverage prepared in example 3 can slow down sports injury and accelerate the repair of sports injury by targeted supplementation.
Examples 5,
In the experimental group, volunteers were given the composition shown in table 7 (one person in table 7 for 1 day) every day instead of the functional drink after exercise, and the same as in example 4. The effect is not significantly different from example 4.
TABLE 7
Claims (6)
1. A composition for providing amino acids comprising the following 7 effective ingredients: hydroxyproline, proline, glutamic acid, theanine, L-leucine, L-isoleucine and L-valine;
the mass ratio of hydroxyproline, proline, glutamic acid, theanine, L-leucine, L-isoleucine and L-valine is as follows in sequence: 0.7: 0.9: 3.6: 0.07: 2.13: 1.12: 1.12;
the raw materials of the composition comprise: wheat protein, whole milk powder, hydrolyzed whey protein peptide, whey protein powder, soybean protein isolate powder, collagen, branched chain amino acid and tea amino acid; the weight ratio of wheat protein, whole milk powder, hydrolyzed whey protein peptide, whey protein powder, soybean protein isolate, collagen, branched chain amino acid and tea amino acid is as follows: 6.37: 4.5: 2.15: 1.5: 1.5: 1.43: 2.8: 0.28.
2. a product, the starting materials comprising: wheat protein, whole milk powder, hydrolyzed whey protein peptide, whey protein powder, soybean protein isolate powder, collagen, branched chain amino acid, tea amino acid, vitamin premix and mineral premix;
the mass ratio of wheat protein, whole milk powder, hydrolyzed whey protein peptide, whey protein powder, soybean protein isolate powder, collagen, branched chain amino acid, tea amino acid, vitamin premix and mineral premix is 6.37: 4.5: 2.15: 1.5: 1.5: 1.43: 2.8: 0.28: 0.13: 0.81;
the vitamin premix comprises the following 12 effective components: the component I-1, the component I-2, the component I-3, the component I-4, the component I-5, the component I-6, the component I-7, the component I-8, the component I-9, the component I-10, the component I-11 and the component I-12; component I-1 provides a substance having a vitamin A function, component I-2 provides a substance having a vitamin B1 function, component I-3 provides a substance having a vitamin B2 function, component I-4 provides a substance having a vitamin B3 function, component I-5 provides a substance having a vitamin B5 function, component I-6 provides a substance having a vitamin B6 function, component I-7 provides a substance having a vitamin B9 function, component I-8 provides a substance having a vitamin B12 function, component I-9 provides a substance having a vitamin C function, component I-10 provides a substance having a vitamin D function, component I-11 provides a substance having a vitamin E function, and component I-12 provides a substance having a vitamin H function; each 1g of the vitamin premix comprises a component I-1, a component I-2, a component I-3, a component I-4, a component I-5, a component I-6, a component I-7, a component I-8, a component I-9, a component I-10, a component I-11 and a component I-12 which are 1100-1650 mu g, 14.22-21.33mg, 7.112-10.67mg, 49.11-73.67mg, 17.33-26.00mg, 7.112-10.67mg, 888.9-1333 mu g, 14.22-21.33 mu g, 255.5-383.3mg, 25.55-38.33 mu g, 49.12-73.68mg and 121.12-181.68 mu g in sequence;
the mineral premix comprises the following 9 effective components: component II-1, component II-2, component II-3, component II-4, component II-5, component II-6, component II-7, component II-8 and component II-9; the component II-1 provides a sodium element, the component II-2 provides a phosphorus element, the component II-3 provides a potassium element, the component II-4 provides a magnesium element, the component II-5 provides a calcium element, the component II-6 provides an iron element, the component II-7 provides a zinc element, the component II-8 provides a selenium element, and the component II-9 provides an iodine element; each 1g of the mineral premix contains sodium provided by the component II-1, phosphorus provided by the component II-2, potassium provided by the component II-3, magnesium provided by the component II-4, calcium provided by the component II-5, iron provided by the component II-6, zinc provided by the component II-7, selenium provided by the component II-8 and iodine provided by the component II-9 in sequence, wherein the contents of the sodium, the phosphorus, the potassium, the magnesium, the calcium, the iron, the zinc, the selenium and the iodine are 85.19-127.8mg, 40.92-61.39mg, 85.18-127.8mg, 13.08-19.61mg, 35.19-52.78mg, 1.2088-1.8134mg, 1.4226-2.134mg, 2.208-3.312 mug and 3.614-5.420 mug;
in the product, hydroxyproline, proline, glutamic acid, theanine, L-leucine, L-isoleucine and L-valine are sequentially mixed according to the mass ratio: 0.7: 0.9: 3.6: 0.07: 2.13: 1.12: 1.12;
the function of the product is as follows (a2) or (a 3):
(a2) preparing a functional beverage to be taken after exercise;
(a3) can be used as functional beverage for patients after exercise.
3. A product, the starting materials comprising: wheat protein, whole milk powder, hydrolyzed whey protein peptide, whey protein powder, soybean protein isolate powder, collagen, branched chain amino acid, tea amino acid, crystalline fructose, fructo-oligosaccharide, sodium carboxymethylcellulose, resistant dextrin, taurine, vitamin premix and mineral premix;
the weight ratio of wheat protein, whole milk powder, hydrolyzed whey protein peptide, whey protein powder, soybean protein isolate powder, collagen, branched chain amino acid, tea amino acid, crystalline fructose, fructo-oligosaccharide, sodium carboxymethylcellulose, resistant dextrin, taurine, vitamin premix and mineral premix is 6.37: 4.5: 2.15: 1.5: 1.5: 1.43: 2.8: 0.28: 5.07: 0.9: 0.8: 1.72: 0.04: 0.13: 0.81;
the vitamin premix comprises the following 12 effective components: the component I-1, the component I-2, the component I-3, the component I-4, the component I-5, the component I-6, the component I-7, the component I-8, the component I-9, the component I-10, the component I-11 and the component I-12; component I-1 provides a substance having a vitamin A function, component I-2 provides a substance having a vitamin B1 function, component I-3 provides a substance having a vitamin B2 function, component I-4 provides a substance having a vitamin B3 function, component I-5 provides a substance having a vitamin B5 function, component I-6 provides a substance having a vitamin B6 function, component I-7 provides a substance having a vitamin B9 function, component I-8 provides a substance having a vitamin B12 function, component I-9 provides a substance having a vitamin C function, component I-10 provides a substance having a vitamin D function, component I-11 provides a substance having a vitamin E function, and component I-12 provides a substance having a vitamin H function; each 1g of the vitamin premix comprises a component I-1, a component I-2, a component I-3, a component I-4, a component I-5, a component I-6, a component I-7, a component I-8, a component I-9, a component I-10, a component I-11 and a component I-12 which are 1100-1650 mu g, 14.22-21.33mg, 7.112-10.67mg, 49.11-73.67mg, 17.33-26.00mg, 7.112-10.67mg, 888.9-1333 mu g, 14.22-21.33 mu g, 255.5-383.3mg, 25.55-38.33 mu g, 49.12-73.68mg and 121.12-181.68 mu g in sequence;
the mineral premix comprises the following 9 effective components: component II-1, component II-2, component II-3, component II-4, component II-5, component II-6, component II-7, component II-8 and component II-9; the component II-1 provides a sodium element, the component II-2 provides a phosphorus element, the component II-3 provides a potassium element, the component II-4 provides a magnesium element, the component II-5 provides a calcium element, the component II-6 provides an iron element, the component II-7 provides a zinc element, the component II-8 provides a selenium element, and the component II-9 provides an iodine element; each 1g of the mineral premix contains sodium provided by the component II-1, phosphorus provided by the component II-2, potassium provided by the component II-3, magnesium provided by the component II-4, calcium provided by the component II-5, iron provided by the component II-6, zinc provided by the component II-7, selenium provided by the component II-8 and iodine provided by the component II-9 in sequence, wherein the contents of the sodium, the phosphorus, the potassium, the magnesium, the calcium, the iron, the zinc, the selenium and the iodine are 85.19-127.8mg, 40.92-61.39mg, 85.18-127.8mg, 13.08-19.61mg, 35.19-52.78mg, 1.2088-1.8134mg, 1.4226-2.134mg, 2.208-3.312 mug and 3.614-5.420 mug;
in the product, hydroxyproline, proline, glutamic acid, theanine, L-leucine, L-isoleucine and L-valine are sequentially mixed according to the mass ratio: 0.7: 0.9: 3.6: 0.07: 2.13: 1.12: 1.12;
the function of the product is as follows (a2) or (a 3):
(a2) preparing a functional beverage to be taken after exercise;
(a3) can be used as functional beverage for patients after exercise.
4. A method of making a product comprising the steps of:
(1) mixing vitamin premix, mineral premix, tea amino acid and taurine to obtain a mixed material A;
(2) mixing the mixture A, soybean protein isolate powder, branched chain amino acid, resistant dextrin, sodium carboxymethylcellulose, fructo-oligosaccharide, collagen, whey protein powder, hydrolyzed whey protein peptide, whole milk powder, crystalline fructose and wheat protein to obtain a product;
the weight ratio of wheat protein, whole milk powder, hydrolyzed whey protein peptide, whey protein powder, soybean protein isolate powder, collagen, branched chain amino acid, tea amino acid, crystalline fructose, fructo-oligosaccharide, sodium carboxymethylcellulose, resistant dextrin, taurine, vitamin premix and mineral premix is 6.37: 4.5: 2.15: 1.5: 1.5: 1.43: 2.8: 0.28: 5.07: 0.9: 0.8: 1.72: 0.04: 0.13: 0.81;
the vitamin premix comprises the following 12 effective components: the component I-1, the component I-2, the component I-3, the component I-4, the component I-5, the component I-6, the component I-7, the component I-8, the component I-9, the component I-10, the component I-11 and the component I-12; component I-1 provides a substance having a vitamin A function, component I-2 provides a substance having a vitamin B1 function, component I-3 provides a substance having a vitamin B2 function, component I-4 provides a substance having a vitamin B3 function, component I-5 provides a substance having a vitamin B5 function, component I-6 provides a substance having a vitamin B6 function, component I-7 provides a substance having a vitamin B9 function, component I-8 provides a substance having a vitamin B12 function, component I-9 provides a substance having a vitamin C function, component I-10 provides a substance having a vitamin D function, component I-11 provides a substance having a vitamin E function, and component I-12 provides a substance having a vitamin H function; each 1g of the vitamin premix comprises a component I-1, a component I-2, a component I-3, a component I-4, a component I-5, a component I-6, a component I-7, a component I-8, a component I-9, a component I-10, a component I-11 and a component I-12 which are 1100-1650 mu g, 14.22-21.33mg, 7.112-10.67mg, 49.11-73.67mg, 17.33-26.00mg, 7.112-10.67mg, 888.9-1333 mu g, 14.22-21.33 mu g, 255.5-383.3mg, 25.55-38.33 mu g, 49.12-73.68mg and 121.12-181.68 mu g in sequence;
the mineral premix comprises the following 9 effective components: component II-1, component II-2, component II-3, component II-4, component II-5, component II-6, component II-7, component II-8 and component II-9; the component II-1 provides a sodium element, the component II-2 provides a phosphorus element, the component II-3 provides a potassium element, the component II-4 provides a magnesium element, the component II-5 provides a calcium element, the component II-6 provides an iron element, the component II-7 provides a zinc element, the component II-8 provides a selenium element, and the component II-9 provides an iodine element; each 1g of the mineral premix contains sodium provided by the component II-1, phosphorus provided by the component II-2, potassium provided by the component II-3, magnesium provided by the component II-4, calcium provided by the component II-5, iron provided by the component II-6, zinc provided by the component II-7, selenium provided by the component II-8 and iodine provided by the component II-9 in sequence, wherein the contents of the sodium, the phosphorus, the potassium, the magnesium, the calcium, the iron, the zinc, the selenium and the iodine are 85.19-127.8mg, 40.92-61.39mg, 85.18-127.8mg, 13.08-19.61mg, 35.19-52.78mg, 1.2088-1.8134mg, 1.4226-2.134mg, 2.208-3.312 mug and 3.614-5.420 mug;
in the product, hydroxyproline, proline, glutamic acid, theanine, L-leucine, L-isoleucine and L-valine are sequentially mixed according to the mass ratio: 0.7: 0.9: 3.6: 0.07: 2.13: 1.12: 1.12;
the function of the product is as follows (a2) or (a 3):
(a2) preparing a functional beverage to be taken after exercise;
(a3) can be used as functional beverage for patients after exercise.
5. The product of the process of claim 4.
6. Use of the composition of claim 1 or the product of claim 2 or 3 or 5 as (b1) or (b 2):
(b1) preparing a functional beverage to be taken after exercise;
(b2) can be used as functional beverage for patients after exercise.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810326524.8A CN108552451B (en) | 2018-04-12 | 2018-04-12 | Functional beverage after sports |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810326524.8A CN108552451B (en) | 2018-04-12 | 2018-04-12 | Functional beverage after sports |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108552451A CN108552451A (en) | 2018-09-21 |
CN108552451B true CN108552451B (en) | 2021-07-27 |
Family
ID=63534816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810326524.8A Active CN108552451B (en) | 2018-04-12 | 2018-04-12 | Functional beverage after sports |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108552451B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111820351A (en) * | 2020-07-23 | 2020-10-27 | 北京冠力体育科技有限公司 | Formula of compound whey protein solid beverage |
CN113080355A (en) * | 2021-04-23 | 2021-07-09 | 江苏金维氨生物工程有限公司 | Amino acid solid beverage capable of rapidly supplementing nutrition and production process thereof |
CN114223820A (en) * | 2021-12-28 | 2022-03-25 | 宣城柏维力生物工程有限公司 | Branched chain amino acid beverage for improving muscle content and preparation method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1586332A (en) * | 2004-07-02 | 2005-03-02 | 杭州娃哈哈集团有限公司 | Functional sport drink and its preparing method |
CN105661235A (en) * | 2016-01-22 | 2016-06-15 | 江苏艾兰得营养品有限公司 | Beverage for supplementing compound nutrients and production method thereof |
CN106259946A (en) * | 2016-08-23 | 2017-01-04 | 江苏朸健生命科技发展有限公司 | A kind of sport nutrition solid beverage and preparation method thereof |
CN106617086A (en) * | 2016-12-30 | 2017-05-10 | 贝克尔(天津)药业有限公司 | Nutritional food capable of enhancing exercise capacity and exercise tolerance |
CN106720373A (en) * | 2016-12-02 | 2017-05-31 | 南通励成生物工程有限公司 | A kind of anti-fatigue solid beverage and preparation method thereof |
-
2018
- 2018-04-12 CN CN201810326524.8A patent/CN108552451B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1586332A (en) * | 2004-07-02 | 2005-03-02 | 杭州娃哈哈集团有限公司 | Functional sport drink and its preparing method |
CN105661235A (en) * | 2016-01-22 | 2016-06-15 | 江苏艾兰得营养品有限公司 | Beverage for supplementing compound nutrients and production method thereof |
CN106259946A (en) * | 2016-08-23 | 2017-01-04 | 江苏朸健生命科技发展有限公司 | A kind of sport nutrition solid beverage and preparation method thereof |
CN106720373A (en) * | 2016-12-02 | 2017-05-31 | 南通励成生物工程有限公司 | A kind of anti-fatigue solid beverage and preparation method thereof |
CN106617086A (en) * | 2016-12-30 | 2017-05-10 | 贝克尔(天津)药业有限公司 | Nutritional food capable of enhancing exercise capacity and exercise tolerance |
Non-Patent Citations (1)
Title |
---|
茶氨酸的生理作用研究及与运动的影响关系;周雪冬;《福建茶业》;20161125(第11期);第26页摘要 * |
Also Published As
Publication number | Publication date |
---|---|
CN108552451A (en) | 2018-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cribb et al. | The effect of whey isolate and resistance training on strength, body composition, and plasma glutamine | |
Gleeson | Dosing and efficacy of glutamine supplementation in human exercise and sport training | |
Juhn | Popular sports supplements and ergogenic aids | |
Miller et al. | Independent and combined effects of amino acids and glucose after resistance exercise | |
CN108552451B (en) | Functional beverage after sports | |
AU784752B2 (en) | Food supplement for increasing lean mass and strength | |
AU2012299126B2 (en) | Compositions and methods for use in promoting lean body mass | |
Fukuda et al. | The possible combinatory effects of acute consumption of caffeine, creatine, and amino acids on the improvement of anaerobic running performance in humans | |
US9066953B2 (en) | Methods for increasing endurance and fat metabolism in humans | |
CN102665445B (en) | Method of enhancing muscle protein synthesis | |
Zhang et al. | Effects of branched-chain amino acid supplementation on plasma concentrations of free amino acids, insulin, and energy substrates in young men | |
AU2016262125B2 (en) | Amino acid supplementation | |
CA2399500A1 (en) | Alpha lipoic acid based food supplement for increasing lean muscle mass and strength | |
KR20020062927A (en) | Food supplement for increasing lean mass and strength | |
Pitkänen et al. | Leucine supplementation does not enhance acute strength or running performance but affects serum amino acid concentration | |
CN105495582A (en) | Anti-fatigue and restorative health-care food amino acid composition | |
WO2020160509A1 (en) | Enhanced nitrate compositions and methods of use | |
JP2002065212A (en) | Food composition for strengthening muscle, and muscle- strengthening agent | |
CN108684999A (en) | A kind of motor function beverage | |
CN101331950B (en) | Nutritional supplement for increasing sports break-out force | |
Jordan et al. | Ergogenic aids and the female athlete | |
CN107125522A (en) | It is a kind of that there is amino acid sports drink of increasing flesh shield bone function and preparation method thereof | |
US9211297B2 (en) | Exercise performance-increasing nutritional supplement and related methods and compositions | |
Piattoly | L-glutamine supplementation: Effects on recovery from exercise | |
Turpin et al. | Systematic and critical evaluation of benefits and possible risks of nutritional ergogenic aids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |